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Bacterial Peritonitis Due to Acinetobacter baumannii Sequence Type
25 with Plasmid-Borne New Delhi Metallo--Lactamase in Honduras
Paige E. Waterman,a Patrick McGann,a Erik Snesrud,a Robert J. Clifford,a Yoon I. Kwak,a Ivón P. Munoz-Urbizo,b
Juana Tabora-Castellanos,b Michael Milillo,a Lan Preston,a Ricardo Aviles,c Deena E. Sutter,d Emil P. Leshoa
Multidrug-resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, Maryland, USAa; Department of Epidemiology,
Hospital Escuela, Tegucigalpa, Hondurasb; Medical Element, Joint Task Force-Bravo, Soto Cano Air Base, Hondurasc; Division of Pediatric Infectious Disease, San Antonio
Military Medical Center, Fort Sam Houston, Texas, USAd
A carbapenem-resistant Acinetobacter baumannii strain was isolated from the peritoneal fluid of a patient with complicated
intra-abdominal infection and evaluated at the Multidrug-resistant Organism Repository and Surveillance Network by whole-
genome sequencing and real-time PCR. The isolate was sequence type 25 and susceptible to colistin and minocycline, with low
MICs of tigecycline. blaNDM-1 was located on a plasmid with >99% homology to pNDM-BJ02. The isolate carried numerous
other antibiotic resistance genes, including the 16S methylase gene, armA.
Carbapenem-resistant Gram-negative organisms are emergingpathogens that threaten global public health and seriously
challenge infection control and therapy efforts (1–3). Though still
relatively uncommon, the carbapenemase encoded by blaNDM has
quickly established itself as one of the most important (4). First
described in 2009 (5), the gene has since been identified in nearly
every continent and has been detected in species as diverse as
Acinetobacter baumannii and Vibrio cholerae (6–8). Furthermore,
the gene has been associated with a diverse range of plasmids that
often harbor multiple antibiotic resistance genes (9).
In 2012, the Multidrug-resistant Organism Repository and
Surveillance Network (MRSN) (10) received a request from a
Ministry of Health hospital in Tegucigalpa, Honduras, for assis-
tance in identifying the genetic mechanism associated with an
extensively drug-resistant (XDR) isolate of A. baumannii. The iso-
late was recovered from a 76-year-old male patient admitted for
ongoing dialysis in the setting of dysfunctional hemodialysis ac-
cess. On the second day of admission, a peritoneal catheter was
placed and the patient was prescribed empirical ciprofloxacin
(250 mg) and a single dose of cephalothin (2 g). Two days later, the
patient developed a fever (38.2°C) and experienced right lower
abdominal pain. Peritoneal fluid cultures revealed moderate
growth of Gram-negative bacilli. The patient was prescribed
ceftriaxone (2 g/day) followed by intravenous ciprofloxacin (200
mg every 12 h) and intraperitoneal ceftazidime (250 mg). The
organism was identified as A. baumannii with resistance to the
fluoroquinolones and -lactams, including carbapenems. Prompt
clinical improvement followed removal of the peritoneal dialysis
catheter and the initiation of tigecycline (50 mg every 12 h). He
was discharged 17 days later and completed a 10-day course of
therapy with tigecycline.
The isolate was forwarded to the MRSN and tested for carbap-
enemase genes by real-time PCR (11). Identification and antibi-
otic susceptibility tests were performed on three automated sys-
tems: the Vitek 2 (bioMérieux, Inc., NC), the BD Phoenix (BD
Diagnostics Systems, MD), and the Microscan Walk-Away (Sie-
mens Healthcare Diagnostics Inc., IL). MICs of colistin, minocy-
cline, polymyxin B, and tigecycline were determined by Etest;
colistin susceptibility was also assayed using broth microdilution.
Whole genome sequencing was performed using an Ion Torrent
Personal Genome Machine (PGM) with 200-bp chemistry.
The isolate (MRSN 12227) was identified as A. baumannii. It
was resistant to amikacin, ampicillin-sulbactam, aztreonam,
cefepime, cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin,
gentamicin, imipenem, levofloxacin, meropenem, tetracycline,
tobramycin, and trimethoprim-sulfamethoxazole using CLSI
breakpoints (12). The isolate was susceptible to minocycline
(MIC  3 g/ml) and to colistin by broth microdilution (MIC 
0.25 g/ml) and Etest (MIC  0.125 g/ml). It had low MICs of
tigecycline (1.5 g/ml) and polymyxin B (0.25 g/ml), which cor-
relate with the successful treatment of the patient with tigecycline.
MRSN 12227 was assigned to sequence type 25 (ST25) (Pasteur
scheme), an ST that has been sporadically identified in a number
of countries, including The Netherlands, Turkey, Greece, Italy,
Sweden, and Singapore, and is not associated with any clonal com-
plex (13, 14). Though sporadic, ST25 appears to be a stable clone
and has been implicated in clinical infections since 1985 (14).
Mean coverage depth for genome assembly was 129-fold.
MRSN 12227 carried blaNDM-1 on a plasmid that shared 99%
homology to pNDM-BJ02, a plasmid initially identified in a clin-
ical isolate of Acinetobacter lwoffii in Beijing, China (15). Interest-
ingly, we also identified this plasmid in a clinical isolate of A.
schindleri recovered from a surveillance groin swab of a U.S. ser-
vice member wounded in Afghanistan (16). This plasmid is un-
classifiable by PCR-based replicon typing, has a novel plasmid
backbone sequence, and carries genes that encode a type IV secre-
tion system (T4SS) that facilitates horizontal transmission (15).
The composition of the genetic region surrounding blaNDM shares
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common elements with other plasmids carrying blaNDM in Enter-
obacteriaceae (17), including the putative bleomycin resistance
gene bleMDL, the N-(5=-phosphoribosyl)anthranilate isomerase
gene trpF, and the insertion sequence ISAba125 (Fig. 1). pNDM-
BJ02 also carries a nonfunctional copy of aphA6, which normally
encodes an aminoglycoside-modifying enzyme (AME) that con-
fers resistance to amikacin. The same genetic architecture is ap-
parent in the plasmid from MRSN 12227, with an upstream trans-
position event seemingly disrupting the promoter region of
aphA6. However, unlike the A. lwoffii (15) and A. schindleri (16)
isolates that also carried this plasmid, MRSN 12227 is resistant to
amikacin. This discrepancy was resolved when further analysis of
the MRSN 12227 genome using ResFinder (18) revealed a chro-
mosomal copy of the 16S methylase gene, armA, which confers
resistance to all aminoglycosides (19) (Table 1). pNDM-BJ02 has
been reported to have a very high frequency of transfer (9.1 
103 to 1.3  102 per donor cell) to Escherichia coli J53 Azir (15).
Our experience with blaNDM-carrying strains of Acinetobacter pro-
vides further evidence for the promiscuity of this plasmid. In both
instances in which the MRSN has encountered blaNDM-carrying
strains of Acinetobacter, pNDM-BJ02 has been its vehicle of trans-
mission.
MRSN 12227 also carries plasmid pCTXM360, which harbors
the -lactamase gene blaCTX-M-15 (20), and has two additional
chromosomal insertions carrying multiple antibiotic resistance
genes (Table 1 and Fig. 1). The first of these carries six antibiotic
resistance loci, including the aforementioned 16S methylase gene
armA and the macrolide resistance genes mphE and msrE (Table 1
FIG 1 Composition of the genetic environment surrounding blaNDM-1 (A), the AbaR resistance island (B), and the 16S methylase gene armA (C). Arrows
indicate gene orientation from 5= to 3=. Relative gene sizes are proportional to the lengths of the arrows. White arrows indicate confirmed or putative functional
genes with hypothetical genes, marked as hyp. Gray arrows indicate transposons, and black bars indicate repeat regions.
TABLE 1 Antibiotic resistance genes carried by MRSN 12227a
Geneb Contigc Locationd Functione Notes
blaOXA-64 1 Chromosome Class D -lactamase blaOXA-51-like
mphE 1 Chromosome Macrolide phosphotransferase Confers resistance to macrolides
msrE 1 Chromosome Macrolide efflux protein Confers resistance to macrolides
armA 1 Chromosome 16S methylase Confers resistance to all aminoglycosides
sul1 1 Chromosome Dihydropteroate synthase Confers resistance to sulfonamides
ant(3)-Ia 1 Chromosome AME aadA2; confers resistance to gentamicin and tobramycin
dfrA-12 1 Chromosome Dihydrofolate reductase Confers resistance to trimethoprim
ceoA-like 6 Chromosome RND efflux pump
ceoB 6 Chromosome RND efflux pump 98% identity to CeoB (protein)f
opcM-like 6 Chromosome RND efflux pump
sul2 38 Chromosome Dihydropteroate synthase Confers resistance to sulfonamides
tetB 38 Chromosome Efflux pump Confers resistance to tetracycline
aph(6)-Id 38 Chromosome AME strB; confers resistance to streptomycin
aph(3)-Ib 38 Chromosome AME strA; confers resistance to streptomycin
blaCTX-M-15 44 pCTXM360 ESBL Confers resistance to cephalosporins and monobactams
aph(3=)-VIa 50 pNDM-BJ02 AME Nonfunctional
blaNDM-1 50 pNDM-BJ02 Class B -lactamase Confers resistance to all -lactams except aztreonam
aac(3)-IIa 56 Putative Plasmid AME Confers resistance to gentamicin and tobramycin
blaTEM-1 59 Unknown ESBL 3 synonymous SNPs
g; resistance to early cephalosporins
a Abbreviations: AME, aminoglycoside-modifying enzyme; ESBL, extended-spectrum -lactamases; SNP, single-nucleotide polymorphism; RND, resistance/nodulation/division.
b Based on closest match to BLAST (http://blast.ncbi.nlm.nih.gov) search.
c The MRSN 12227 whole-genome sequence was assembled into 95 contigs. The relative sizes of the reported contigs (in base pairs) are as follows: contig 1, 383,184; contig 6,
197,316; contig 38, 23,159; contig 44, 13,686; contig 50, 8,127; contig 56, 1,720; and contig 59, 1,375.
d Putative or confirmed location of the respective antibiotic resistance gene based on whole-genome sequencing.
e Confirmed or putative function of protein.
f Confers resistances to chloramphenicol, trimethoprim, and ciprofloxacin.
g blaTEM-1contains 3 synonymous mutations compared to the reference blaTEM-1 sequence (26). pCTXM-360 contains blaTEM in close proximity to blaCTX-M-15, but the exact
location of blaTEM-1 is still uncertain.
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and Fig. 1). This structure has been identified on plasmids associ-
ated with Klebsiella oxytoca and Citrobacter freundii (GenBank ac-
cession numbers CP003684.1 and JX182975.1, respectively) and
on the chromosome of A. baumannii MDR-TJ and TYTH-1 (21,
22). The second region also includes multiple antibiotic resistance
genes, including the tetracycline efflux gene tetB, the streptomycin
resistance genes strA and strB, and the dihydropteroate synthase
gene sul2. This region most closely resembles the Acinetobacter
resistance island AbaR1 (23), which is widely distributed in Acin-
etobacter baumannii strains. MRSN 12227 carries the chromo-
somally encoded blaOXA-51-like gene blaOXA-64 but does not carry
any acquired class D carbapenemase genes, indicating that car-
bapenemase resistance in this strain is probably due to blaNDM-1.
This is the first report of blaNDM from Honduras, and it follows
the recent identification of this gene in a strain of Klebsiella pneu-
moniae in neighboring Guatemala (24). The current epidemiolog-
ical evidence from the hospital supports nosocomial transmission
of MRSN 12227, but further investigations are ongoing. The mod-
ified Hodge test and the Carba NP tests were both negative for
MRSN 12227, but this is not unexpected for Acinetobacter (25).
Finally, pNDM-BJ02 appears to be emerging as a common vehicle
for the horizontal transmission of blaNDM, particularly in Acineto-
bacter species. In vitro evidence suggests that this plasmid is highly
promiscuous, and further research is warranted to see if this plas-
mid is capable of being transmitted and stably maintained in other
clinically important bacteria.
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